Since Canada began allowing recreational marijuana sales last October, Aurora Cannabis (NYSE: ACB) stock has fallen around 44% thanks to underwhelming sales and heavy operating losses. Recently released revenue results for the period ended June 30, 2019, disappointed analysts that were expecting more, but investors shouldn't give hope just yet.
Despite missing some lofty revenue expectations, there were signs of positive cash flows ahead. These are the top four that investors should know about.
Aurora Cannabis is still losing money, but it took a significant step in the right direction during the company's fiscal fourth quarter, which ended on June 30, 2019. If revenues and expenses recorded during the last three months of fiscal 2019 stays glued in place for all of fiscal 2020, shareholders won't have a lot to complain about.